Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas

NCT02507232 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped low enrollment

Conditions

Glioma

Interventions

DEVICE: NovoTTF-200A
DRUG: Temozolomide

Sponsor

Santosh Kesari

Collaborators

[object Object]